International Journal of Medical and All Body Health Research  |  e-ISSN: 2582-8940  |  Double-Blind Peer Review  |  Open Access  |  CC BY-NC-SA 4.0

Current Issues
     2026:7/4

International Journal of Medical and All Body Health Research

e-ISSN: 2582-8940 | Open Access

Impact of COVID-19 on the Risk of Developing Dermatological Conditions

Rehman Basharat

Stony Brook University, New York, 11794, United States

Article Information

Volume / Issue5 / 4 (October-December 2024)
Pages45-48
AccessOpen Access

Publication Timeline

  • Received10 August 2024
  • Accepted13 September 2024

Full Text (PDF)

Open Access - Free to Download

Download Full Article (PDF) JATS XML

Abstract

Introduction: The COVID-19 pandemic, caused by SARS-CoV-2, has impacted global health across various medical domains, including dermatology. Dermatological manifestations are increasingly recognized in COVID-19 patients. This study aimed to evaluate the risk of developing dermatological conditions in patients with COVID-19 compared to non-COVID patients.

Methods: This retrospective cohort study analyzed electronic health records (EHRs) from January 1, 2020, to January 1, 2022, including two cohorts: COVID-19 patients with confirmed diagnoses and non-COVID patients. The primary outcome was the development of new dermatological conditions within three months of the index date. Risk differences and risk ratios (RRs) were calculated to compare the cohorts. Confounding factors such as age, sex, race, and ethnicity were controlled during the statistical analysis. Statistical significance was set at p < 0.05.

Results: COVID-19 patients exhibited a significantly reduced risk for various dermatological conditions, including acne vulgaris (RR = 0.671), atopic dermatitis (RR = 0.649), and seborrheic dermatitis (RR = 0.606), among others. Certain rarer conditions, such as lichen planus (RR = 0.585) and basal cell carcinoma (RR = 0.517), also showed a decreased incidence. However, pallor was significantly more prevalent in COVID-19 patients (RR = 2.328), suggesting systemic vascular involvement.

Conclusion: The findings indicate a reduced risk for many dermatological conditions in COVID-19 patients, possibly due to immune modulation and vascular alterations by the virus. Pallor’s increased prevalence in these patients underscores the broader systemic effects of COVID-19. These results contribute to our understanding of COVID-19's dermatological impacts, offering insights for better patient management and future research into the long-term effects on skin health.

Keywords

COVID-19Dermatological manifestationsRisk assessment

References

  1. Cucinotta D, Vanelli M. WHO declares COVID‐19 a pandemic. Acta Biomed. 2020;91:157‐160. [Google Scholar][Crossref]
  2. Worldmeter. Coronavirus Cases. Available online: https://www.worldometers.info/coronavirus/ (ac cessed on 1 June 2022). [Google Scholar][Crossref]
  3. Mungmunpuntipantip R, Wiwanitkit V. COVID‐19 and cutaneous manifestations. J Eur Acad Dermatol Venereol. 2020;34(6):e246. doi: 10.1111/jdv.16483 [Google Scholar][Crossref]
  4. Su CJ, Lee CH. Viral exanthem in COVID‐19, a clinical enigma with biological significance. J Eur Acad Dermatol Venereol. 2020;34(6):e251‐e252. doi: 10.1111/jdv.16469 [Google Scholar][Crossref]
  5. Pendlebury GA, Oro P, Haynes W, Merideth D, Bartling S, Bongiorno MA. The Impact of COVID-19 Pandemic on Dermatological Conditions: A Novel, Comprehensive Review. Dermatopathology. 2022; 9(3):212-243. https://doi.org/10.3390/dermatopathology9030027 [Google Scholar][Crossref]
  6. Carrascosa JM, Morillas V, Bielsa I, Munera‐Campos M. Cutaneous manifestations in the context of SARS‐ CoV‐2 infection (COVID‐19). Actas Dermosifiliogr. 2020;111(9):734‐742. doi: 10.1016/j.ad.2020.08.002 [Google Scholar][Crossref]
  7. Galvan‐Casas C, Catala A, Carretero G, Rodriguez‐ Jimenez P. Classification of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71‐77. doi: 10.1111/bjd.19163 [Google Scholar][Crossref]
  8. Drenovska K, Schmidt E, Vassileva S. Covid‐19 pandemic and the skin. Int J Dermatol. 2020;59(11):1312‐1319. doi: 10.1111/ijd.15189 [Google Scholar][Crossref]
  9. Montazersaheb, S., Hosseiniyan Khatibi, S.M., Hejazi, M.S. et al. COVID-19 infection: an overview on cytokine storm and related interventions. Virol J 19, 92 (2022). https://doi.org/10.1186/s12985-022-01814-1 [Google Scholar][Crossref]
  10. Li J, Zhang Y, Luo B. Effects of Exosomal Viral Components on the Tumor Microenvironment. Cancers (Basel). 2022;14(14):3552. doi: 10.3390/cancers14143552. PMID: 35884611; PMCID: PMC9317196. [Google Scholar][Crossref]
  11. Al-Beltagi M, Saeed NK, Bediwy AS. COVID-19 disease and autoimmune disorders: A mutual pathway. World J Methodol. 2022;12(4):200-223. doi: 10.5662/wjm.v12.i4.200. PMID: 36159097; PMCID: PMC9350728. [Google Scholar][Crossref]
  12. Bergamaschi G, Borrelli de Andreis F, Aronico N, Lenti MV, Barteselli C, Merli S, et al. Internal Medicine Covid-19 Collaborators. Anemia in patients with Covid-19: pathogenesis and clinical significance. Clin Exp Med. 2021;21(2):239-246. doi: 10.1007/s10238-020-00679-4. Epub 2021 Jan 8. Erratum in: Clin Exp Med. 2021 May;21(2):247. doi: 10.1007/s10238-021-00699-8. PMID: 33417082; PMCID: PMC7790728. Copyright and License © The Author(s). Authors retain the copyright of their published articles. This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution Non Commercial-Share A like 4.0 International (CC BY-NC-SA 4.0) License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. [Google Scholar][Crossref]

How to Cite

Basharat, R. (2024). Impact of COVID-19 on the Risk of Developing Dermatological Conditions. International Journal of Medical and All Body Health Research, 5(4), 45-48. https://doi.org/10.54660/IJMBHR.2024.5.4.45-48

Basharat, Rehman. "Impact of COVID-19 on the Risk of Developing Dermatological Conditions." International Journal of Medical and All Body Health Research, vol. 5, no. 4, 2024, pp. 45-48. https://doi.org/10.54660/IJMBHR.2024.5.4.45-48.

Basharat, R. (2024) 'Impact of COVID-19 on the Risk of Developing Dermatological Conditions', International Journal of Medical and All Body Health Research, 5(4), pp. 45-48. doi: 10.54660/IJMBHR.2024.5.4.45-48.

Basharat R. Impact of COVID-19 on the Risk of Developing Dermatological Conditions. International Journal of Medical and All Body Health Research. 2024;5(4):45-48. doi:10.54660/IJMBHR.2024.5.4.45-48

Similar Articles

Share

Find this Article on

Google Scholar Semantic Scholar OpenAlex Scilit Crossref ResearchGate BASE

A newly published article may take a few days to appear on these services.